AU753077B2 - Combination of a GABA-A alpha 5 inverse agonist and an acetylcholinesterase inhibitor - Google Patents

Combination of a GABA-A alpha 5 inverse agonist and an acetylcholinesterase inhibitor Download PDF

Info

Publication number
AU753077B2
AU753077B2 AU28464/99A AU2846499A AU753077B2 AU 753077 B2 AU753077 B2 AU 753077B2 AU 28464/99 A AU28464/99 A AU 28464/99A AU 2846499 A AU2846499 A AU 2846499A AU 753077 B2 AU753077 B2 AU 753077B2
Authority
AU
Australia
Prior art keywords
inverse agonist
hydrochloride
receptor subtype
yl
gabaa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU28464/99A
Other versions
AU2846499A (en
Inventor
Gerard Raphael Dawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9805561 priority Critical
Priority to GBGB9805561.9A priority patent/GB9805561D0/en
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme Ltd
Priority to PCT/GB1999/000778 priority patent/WO1999047131A2/en
Publication of AU2846499A publication Critical patent/AU2846499A/en
Application granted granted Critical
Publication of AU753077B2 publication Critical patent/AU753077B2/en
Anticipated expiration legal-status Critical
Application status is Ceased legal-status Critical

Links